Trial: 202108004

A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, formerly PT2977) Monotherapy in Participants with Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET)

Phase

II (Cancer Control)

Principal Investigator

Trikalinos, Nikolaos

Disease Site

Other Endocrine System; Pancreas

Learn more about this study at: clinicaltrials.gov